<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>EXTRACTION OF DRUG-DRUG INTERACTIONS USING ALL PATHS GRAPH KERNEL.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>Shreyas Karnik</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Abhinita Subhadarshini</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Zhiping Wang</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Luis M. Rocha</string-name>
          <xref ref-type="aff" rid="aff2">2</xref>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Lang Li</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>Center for Computational Biology &amp; Bioinformatics, School of Medicine, Indiana University</institution>
          ,
          <addr-line>Indianapolis, IN, USA, 46202</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Department of Medical &amp; Molecular Genetics, School of Medicine, Indiana University</institution>
          ,
          <addr-line>Indianapolis, IN, USA, 46202</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>Instituto Gulbenkian de Ciencia</institution>
          ,
          <addr-line>Oeiras</addr-line>
          ,
          <country country="PT">Portugal</country>
        </aff>
        <aff id="aff3">
          <label>3</label>
          <institution>School of Informatics &amp; Computing, Indiana University</institution>
          ,
          <addr-line>Bloomington, IN, USA, 47408</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
        <aff id="aff4">
          <label>4</label>
          <institution>School of Informatics, Indiana University</institution>
          ,
          <addr-line>Indianapolis, IN, USA, 46202</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
      </contrib-group>
      <abstract>
        <p>Drug-drug interactions (DDIs) cause nearly 3% of all hospital admissions. Regulatory authorities such as the Food and Drug Administration (FDA) and the pharmaceutical companies keep a rigorous tab on the DDIs. The major source of DDI information is the biomedical literature. In this paper we present a DDI extraction approach based on all paths graph kernel [1] from the DrugDDI corpus [2]. We also evaluate the method on an in-house developed clinical in vivo pharmacokinetic DDI corpus. When the DDI extraction model was evaluated on the test dataset from both corpora we recorded a F-score of 0.658 on the clinical in vivo pharmacokinetic DDI corpus and 0.16 on the DrugDDI corpus.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>-</title>
      <p>
        Polypharmacy has been a general clinical practice. More than 70% of old
population (age &gt;65) take more than 3 medications at the same time in US and
some European countries. Since more than 80% of the drugs on the market are
metabolized by the Cytochrome P450 enzyme system, and many of these drugs
are inhibitors and inducers of CYP450 enzyme system, drug interactions have
been extensively investigated in vitro and in vivo [
        <xref ref-type="bibr" rid="ref3 ref4 ref5">3,4,5</xref>
        ]. These DDIs in many
ways affect the overall effectiveness of the drug or at some times pose a risk of
serious side effects to the patients [
        <xref ref-type="bibr" rid="ref6">6</xref>
        ]. Thus, it becomes very challenging to for
the successful drug development and clinical patient care. Regulatory
authorities such as the Food and Drug Administration (FDA) and the pharmaceutical
companies keep a rigorous tab on the DDIs. Major source of DDI information
is the biomedical literature. Due to the unstructured nature of the free text in
the biomedical literature it is difficult and laborious process to extract and
analyze the DDIs from biomedical literature. With the exponential growth of the
&amp;
+
,
! -(
&amp; (
! . "
/
biomedical literature, there is a need for automatic information extraction (IE)
systems that aim at extracting DDIs from biomedical literature. The use of IE
systems to extract relationship among biological entities from biomedical
literature has experienced success to a great scope [
        <xref ref-type="bibr" rid="ref7">7</xref>
        ] for example protein-protein
interaction extraction. Researchers have now started to investigate DDI IE from
biomedical literature. Some early attempts include retrieval of DDI relevant
articles from MEDLINE [
        <xref ref-type="bibr" rid="ref8">8</xref>
        ] ;DDI extraction based on reasoning approach [
        <xref ref-type="bibr" rid="ref9">9</xref>
        ]; DDI
extraction based on shallow parsing and linguistic rules[
        <xref ref-type="bibr" rid="ref10">10</xref>
        ];and DDI extraction
based on shallow linguistic kernel [
        <xref ref-type="bibr" rid="ref2">2</xref>
        ].
      </p>
      <p>
        BioCreAtIvE has established the standard of evaluation methods and datasets
in the area of information extraction [
        <xref ref-type="bibr" rid="ref11 ref12 ref13 ref7">7,11,12,13</xref>
        ] which has been a asset for the
community. To encourage the involvement of the community in the DDI
extraction Segura-Bedmar et al.[
        <xref ref-type="bibr" rid="ref2">2</xref>
        ] released an annotated corpus of DDIs (DrugDDI
corpus) from the biomedical literature and organized the DDIExtraction2011
challenge.
      </p>
      <p>
        In this article, we implement the all paths graph kernel [
        <xref ref-type="bibr" rid="ref1">1</xref>
        ] to extract DDIs
from the DrugDDI corpus. We also test the all paths graph kernel approach on
in-house corpus that has annotations of pharmacokinetic DDIs from MEDLINE
abstracts.
      </p>
      <p>The paper is organized as follows, section 2.1 and 2.2 describe the datasets,
section 2.3 describes the all paths graph kernel approach and section 3 describes
the results.
2</p>
    </sec>
    <sec id="sec-2">
      <title>Methodology</title>
      <p>
        DrugDDI Corpus We used the unified format [
        <xref ref-type="bibr" rid="ref14">14</xref>
        ] of the DrugDDI corpus
[
        <xref ref-type="bibr" rid="ref2">2</xref>
        ] of the DrugDDI corpus. Detailed description of the corpus can be found at
DrugDDI Corpus.
2.1
      </p>
      <sec id="sec-2-1">
        <title>Clinical in-vivo pharmacokinetic DDI corpus</title>
        <p>
          Our research group has been studying clinical DDIs reported in biomedical
literature (MEDLINE abstracts) and extraction of numerical pharmacokinetic (PK)
data from them[
          <xref ref-type="bibr" rid="ref15">15</xref>
          ]. During this process, we have collected MEDLINE abstracts
that contain clinical PK DDIs, and further develop them into a PK DDI
corpus. We decided that the ultimate goal of this task is extraction of DDIs from
biomedical literature and it will be interesting to use this corpus as an additional
resource. This corpus comprises of 219 MEDLINE abstracts which contains one
or more of PK DDIs in same sentences. Here we call it PK-DDI corpus. Please
note that a PK DDI means that one drugs exposure is changed by the
coadministration of the other drug. As DrugDDI corpus focuses mainly on DDIs
that change drug effects, our PK-DDI corpus is a good complementary source. In
order to identify drugs in our PK-DDI corpus, we developed a dictionary based
tagging approach using all the drug name entries in DrugBank [
          <xref ref-type="bibr" rid="ref16">16</xref>
          ]. The corpus
was converted into the unified format as proposed in [
          <xref ref-type="bibr" rid="ref14">14</xref>
          ]. The DDI instances
*
"
"
were annotated based on guidelines from in-house experts. We split the corpus
into training (80%) and testing (20%) fractions. This corpus will also be made
public on the lines of the DrugDDI corpus. There are 825 true DDI pairs present
in our corpus.
2.2
        </p>
      </sec>
      <sec id="sec-2-2">
        <title>All paths graph kernel</title>
        <p>
          We implemented the approach described by Airola et al. [
          <xref ref-type="bibr" rid="ref1">1</xref>
          ] for DDI
extraction. This approach centers around the drugs, where a graph representation of
the sentence is generated. Sentences are described as dependency graphs with
interacting components (drugs). The dependency graph is composed of two
unconnected sub-graphs: i) One sub-graph explores the dependency structure of
the sentence; ii) the other explores the linear order of the words in the sentence.
We used the Stanford parser [
          <xref ref-type="bibr" rid="ref17">17</xref>
          ]to generate the dependency graphs for both
corpora. IIn the dependency graph, the shortest path between two entities was
given higher weight as compared to other edges, this is because the shortest path
contains important keywords which are indicative of interaction between two
entities. In the linear sub-graph, all the edges have the same weight and the order
in which words occur before, in the middle, or after drug mentions was
considered. The all paths graph kernel algorithm [
          <xref ref-type="bibr" rid="ref18">18</xref>
          ] was subsequently implemented to
compute the similarity between the graphical representations of the sentences.
In particular, all paths graph kernels will be generated for tagger positive DDI
sentences and negative DDI sentences. We then used Support Vector Machines
(SVM) for classification. More details about the all paths graph kernel algorithm
can be found in [
          <xref ref-type="bibr" rid="ref1">1</xref>
          ]. A pictorial representation of the approach is presented in
figure 1.
3
        </p>
      </sec>
    </sec>
    <sec id="sec-3">
      <title>Results</title>
      <p>In this study we used an in-house corpus in addition to the DrugDDI corpus;
both corpora contain training and testing subsets. We generated DDI extraction
models based on both the training datasets individually and combined, and
evaluated the performance of the DDI extraction models on the respective testing
datasets.</p>
      <p>Table 1 illustrates the summary of training and testing data in two corpuses.
For the purpose of evaluation we used precision, recall and the balanced F-Score
measure. We also performed 10-fold cross-validation during the training phase.</p>
      <p>Table 2 displays the DDI extraction performance on DDI-PK corpus testing
data. It suggests that using the DDI-PK corpus training data either with or
without the DrugDDI corpus training data, led to the precision above 0.78 and
recall above 0.64. On the other hand, if only the DrugDDI corpus was used, both
precision and recall were around 0.41.</p>
      <p>Table 3 displays the DDI extraction performance on DrugDDI corpus testing
data. It suggests that all there models had similar perform in F-score, which was
between 0.13 and 0.16, although using DDI PK corpus generated slightly better
F-score than the other two approaches.
&amp;
+
,
! -(
&amp; (
! . "
/
"</p>
      <p>"
There is large room for improvement in the DDI extraction from the biomedical
literature. We also learned that the in-house DDI PK corpus and Drug DDI
corpus have different DDI structures. It seems the all paths graph kernel method
performed better in DDI PK corpus than the Drug DDI corpus.</p>
      <p>The apparent low precision and recall in the Drug DDI corpus may result
from the fact that the number of real DDIs is much less than the number of
false DDIs in both corpus, but a comparison with the results of other teams is
forthcoming once those get released. It is also possible that the weights on the
sub-graph need to be further adjusted to get a better performance. We noticed
a marked performance difference between the training corpora. The sentences in
the DrugDDI corpus were long and complex. On the other hand, our DDI PK
corpus has a simply sentence structure, and there is an average of one to two
DDI pairs per abstract. Even with the same algorithm, these major differences
between two corpora resulted in different DDI extraction performances.</p>
      <p>DrugDDI corpus focuses on DDIs that affect the clinical outcomes (i.e.
pharmacodynamics DDI); while PK DDI corpus focuses on DDIs that change the
drug exposure. They are complementary to each other. Therefore, our work
enriches the set of resources and analysis available to this community.
,</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="ref1">
        <mixed-citation>
          1.
          <string-name>
            <surname>Airola</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Pyysalo</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Bjorne</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Pahikkala</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ginter</surname>
            ,
            <given-names>F.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Salakoski</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          :
          <article-title>Allpaths graph kernel for protein-protein interaction extraction with evaluation of cross-corpus learning</article-title>
          .
          <source>BMC Bioinformatics 9(Suppl 11)</source>
          (
          <year>2008</year>
          ) S2
        </mixed-citation>
      </ref>
      <ref id="ref2">
        <mixed-citation>
          2.
          <string-name>
            <surname>Segura-Bedmar</surname>
            ,
            <given-names>I.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Martnez</surname>
            , P., de Pablo-Snchez,
            <given-names>C.</given-names>
          </string-name>
          :
          <article-title>Using a shallow linguistic kernel for drug-drug interaction extraction</article-title>
          .
          <source>Journal of Biomedical</source>
          Informatics In Press, Corrected Proof (
          <year>2011</year>
          )
          <article-title>-</article-title>
        </mixed-citation>
      </ref>
      <ref id="ref3">
        <mixed-citation>
          3.
          <string-name>
            <surname>Zhou</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <given-names>Yung</given-names>
            <surname>Chan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>S.</given-names>
            ,
            <surname>Cher Goh</surname>
          </string-name>
          ,
          <string-name>
            <given-names>B.</given-names>
            ,
            <surname>Chan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>E.</given-names>
            ,
            <surname>Duan</surname>
          </string-name>
          ,
          <string-name>
            <given-names>W.</given-names>
            ,
            <surname>Huang</surname>
          </string-name>
          ,
          <string-name>
            <given-names>M.</given-names>
            ,
            <surname>McLeod</surname>
          </string-name>
          ,
          <string-name>
            <surname>H.L.</surname>
          </string-name>
          :
          <article-title>Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs</article-title>
          .
          <source>Clinical Pharmacokinetics</source>
          <volume>44</volume>
          (
          <issue>3</issue>
          ) (
          <year>2005</year>
          )
          <fpage>279</fpage>
          -
          <lpage>304</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref4">
        <mixed-citation>
          4.
          <string-name>
            <surname>Cupp</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Tracy</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          :
          <article-title>Cytochrome P450: New nomenclature and clinical implications</article-title>
          .
          <source>American Family Physician</source>
          <volume>57</volume>
          (
          <issue>1</issue>
          ) (
          <year>1998</year>
          )
          <fpage>107</fpage>
        </mixed-citation>
      </ref>
      <ref id="ref5">
        <mixed-citation>
          5.
          <string-name>
            <surname>Lin</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Lu</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>Inhibition and induction of cytochrome P450 and the clinical implications</article-title>
          .
          <source>Clinical pharmacokinetics 35(5)</source>
          (
          <year>1998</year>
          )
          <fpage>361</fpage>
          -
          <lpage>390</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref6">
        <mixed-citation>
          6.
          <string-name>
            <surname>Sabers</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Gram</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          :
          <article-title>Newer anticonvulsants: Comparative review of drug interactions and adverse effects</article-title>
          .
          <source>Drugs</source>
          <volume>60</volume>
          (
          <issue>1</issue>
          ) (
          <year>2000</year>
          )
          <fpage>23</fpage>
          -
          <lpage>33</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref7">
        <mixed-citation>
          7.
          <string-name>
            <surname>Hirschman</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Yeh</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Blaschke</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Valencia</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>Overview of biocreative: critical assessment of information extraction for biology</article-title>
          .
          <source>BMC Bioinformatics 6(Suppl 1)</source>
          (
          <year>2005</year>
          ) S1
        </mixed-citation>
      </ref>
      <ref id="ref8">
        <mixed-citation>
          8.
          <string-name>
            <surname>Duda</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Aliferis</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Miller</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Statnikov</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Johnson</surname>
          </string-name>
          , K.:
          <article-title>Extracting drug-drug interaction articles from MEDLINE to improve the content of drug databases</article-title>
          . In:
          <article-title>American Medical Informatics Association (AMIA) Annual Symposium proceedings</article-title>
          , American Medical Informatics Association (
          <year>2005</year>
          )
          <fpage>216</fpage>
          -
          <lpage>220</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref9">
        <mixed-citation>
          9.
          <string-name>
            <surname>Tari</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Anwar</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Liang</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Cai</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Baral</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          :
          <article-title>Discovering drug-drug interactions: A text-mining and reasoning approach based on properties of drug metabolism</article-title>
          .
          <source>Bioinformatics</source>
          <volume>26</volume>
          (
          <issue>18</issue>
          ) (
          <year>2010</year>
          )
          <fpage>i547</fpage>
          -
          <lpage>i553</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref10">
        <mixed-citation>
          10.
          <string-name>
            <surname>Segura-Bedmar</surname>
            ,
            <given-names>I.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Martinez</surname>
          </string-name>
          , P.,
          <string-name>
            <surname>de Pablo-Sanchez</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          :
          <article-title>A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents</article-title>
          .
          <source>BMC Bioinformatics 12(Suppl 2)</source>
          (
          <year>2011</year>
          ) S1
        </mixed-citation>
      </ref>
      <ref id="ref11">
        <mixed-citation>
          11.
          <string-name>
            <surname>Yeh</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Morgan</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Colosimo</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Hirschman</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          :
          <article-title>Biocreative task 1a: gene mention finding evaluation</article-title>
          .
          <source>BMC Bioinformatics 6(Suppl 1)</source>
          (
          <year>2005</year>
          ) S2
        </mixed-citation>
      </ref>
      <ref id="ref12">
        <mixed-citation>
          12.
          <string-name>
            <surname>Hirschman</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Colosimo</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Morgan</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Yeh</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>Overview of biocreative task 1b: normalized gene lists</article-title>
          .
          <source>BMC Bioinformatics 6(Suppl 1)</source>
          (
          <year>2005</year>
          ) S11
        </mixed-citation>
      </ref>
      <ref id="ref13">
        <mixed-citation>
          13.
          <string-name>
            <surname>Blaschke</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Leon</surname>
            ,
            <given-names>E.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Krallinger</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Valencia</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          :
          <article-title>Evaluation of biocreative assessment of task 2</article-title>
          .
          <source>BMC Bioinformatics 6(Suppl 1)</source>
          (
          <year>2005</year>
          ) S16
        </mixed-citation>
      </ref>
      <ref id="ref14">
        <mixed-citation>
          14.
          <string-name>
            <surname>Pyysalo</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Airola</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Heimonen</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Bjorne</surname>
            ,
            <given-names>J.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ginter</surname>
            ,
            <given-names>F.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Salakoski</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          :
          <article-title>Comparative analysis of five protein-protein interaction corpora</article-title>
          .
          <source>BMC Bioinformatics 9(Suppl 3)</source>
          (
          <year>2008</year>
          ) S6
        </mixed-citation>
      </ref>
      <ref id="ref15">
        <mixed-citation>
          15.
          <string-name>
            <surname>Wang</surname>
            ,
            <given-names>Z.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Kim</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Quinney</surname>
            ,
            <given-names>S.K.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Guo</surname>
            ,
            <given-names>Y.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Hall</surname>
            ,
            <given-names>S.D.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Rocha</surname>
            ,
            <given-names>L.M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Li</surname>
            ,
            <given-names>L.</given-names>
          </string-name>
          :
          <article-title>Literature mining on pharmacokinetics numerical data: A feasibility study</article-title>
          .
          <source>Journal of Biomedical Informatics</source>
          <volume>42</volume>
          (
          <year>2009</year>
          )
          <fpage>726</fpage>
          -
          <lpage>735</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref16">
        <mixed-citation>
          16.
          <string-name>
            <surname>Knox</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Law</surname>
            ,
            <given-names>V.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Jewison</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Liu</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Ly</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Frolkis</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Pon</surname>
            ,
            <given-names>A.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Banco</surname>
            ,
            <given-names>K.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Mak</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Neveu</surname>
            ,
            <given-names>V.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Djoumbou</surname>
            ,
            <given-names>Y.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Eisner</surname>
            ,
            <given-names>R.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Guo</surname>
            ,
            <given-names>A.C.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Wishart</surname>
            ,
            <given-names>D.S.:</given-names>
          </string-name>
          <article-title>DrugBank 3.0: A comprehensive resource for 'Omics' research on drugs</article-title>
          .
          <source>Nucleic Acids Research</source>
          (
          <year>2010</year>
          )
        </mixed-citation>
      </ref>
      <ref id="ref17">
        <mixed-citation>
          17.
          <string-name>
            <surname>De Marneffe</surname>
            ,
            <given-names>M.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>MacCartney</surname>
            ,
            <given-names>B.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Manning</surname>
            ,
            <given-names>C.</given-names>
          </string-name>
          :
          <article-title>Generating typed dependency parses from phrase structure parses</article-title>
          .
          <source>In: Proceedings of LREC. Volume</source>
          <volume>6</volume>
          .,
          <string-name>
            <surname>Citeseer</surname>
          </string-name>
          (
          <year>2006</year>
          )
          <fpage>449</fpage>
          -
          <lpage>454</lpage>
        </mixed-citation>
      </ref>
      <ref id="ref18">
        <mixed-citation>
          18.
          <string-name>
            <surname>Gartner</surname>
            ,
            <given-names>T.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Flach</surname>
            ,
            <given-names>P.</given-names>
          </string-name>
          ,
          <string-name>
            <surname>Wrobel</surname>
            ,
            <given-names>S.</given-names>
          </string-name>
          :
          <article-title>On graph kernels: Hardness results and efficient alternatives</article-title>
          .
          <source>In: Learning theory and Kernel machines: 16th Annual Conference on Learning Theory and 7th Kernel Workshop</source>
          , COLT/Kernel 2003, Washington, DC, USA,
          <year>August</year>
          24-
          <issue>27</issue>
          ,
          <year>2003</year>
          : proceedings, Springer Verlag (
          <year>2003</year>
          )
          <fpage>129</fpage>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>